from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2821c/-

LFCtreatmentdescriptionclass of inhibitor

-1.253

Amikacinug/mL Amikacintranslation

-1.161

Cap5-10ug/mL Capreomycintranslation

-2.023

Rox10-50 ug/mL Roxithromycintranslation

0.775

SM2-5 ug/mL Streptomycintranslation

-2.224

Tet5-10 ug/mL Tetracyclinetranslation

0.364

Rif0.2-5ug/mL Rifampicintranscription

0.603

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.158

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.644

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.337

CPZ10-50 ug/mL Chlorpromazinerespiration

0.504

Clofazimine10-13 ug/mL Clofaziminerespiration

0.704

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.668

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.430

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.068

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.801

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.056

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.385

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.282

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.926

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.820

KCN5-20 ug/mL Potassium cyaniderespiration

0.617

NaN30.2-2 mM Sodium aziderespiration

0.182

Nigericin50 uM Nigericinrespiration

-0.113

TRC10-150 ug/mL Triclosanrespiration

0.386

TRZ10-25 ug/mL Thioridazinerespiration

0.432

Valinomycin0.5-10 uM Valinomycinrespiration

1.487

ZnSO42 mM ZnSO4respiration

0.843

menadione6-10 ug/mL Menadionerespiration

0.449

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.083

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.297

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.958

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.563

NRP_1Non-replicating persistence stage 1dosRassociated

-0.077

Amp0.2mg/mL AmpicillincellWall

0.268

Cephalexin20-100 ug/mL CephalexincellWall

-0.316

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.031

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.103

EMB10-20 ug/mL EthambutolcellWall

0.688

Eta12-40 ug/mL EthionamidecellWall

-0.066

INH0.2-0.4 ug/mL IsoniazidcellWall

0.318

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.317

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.282

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.373

BZA0.12 mg/mL BenzamidearomaticAmides

-0.548

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.646

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.352

H2O24 mM hydrogen peroxideDNAdamaging

0.014

Levo10 ug/mL LevofloxacinDNAdamaging

-0.405

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-2.374

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.093

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.350

UVUV-irradiationDNAdamaging

2.414

ARP41-4 ug/mL Antitubercular compound ARP4?

0.575

Antimycin12.5-50 ug/mL Antimycin A?

0.677

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.938

PA_110-50 ug/mL Antitubercular compound PA-1?

1.316

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.717

PA8240.2-2 ug/mL PA-824?

-0.639

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.150

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.062

Verapamil50 uM Verapamil?

1.294

mercaptoethanol2 mM 2-Mercaptoethanol?

0.969

methoxatin10-20 ug/mL Methoxatin?